The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Sympathetic overactivity in hypertension. A moving target
Abstract
Considerable progress has been made in our understanding of the role of the nervous system in human hypertension. The evidence for a widespread autonomic abnormality in the early phases of hypertension is overwhelming and excessive sympathetic activity is consistently present in such patients since their childhood. The enhanced sympathetic tone in hypertension is associated with the metabolic syndrome of insulin resistance and dyslipidemia. Multiple mechanisms by which sympathetic overactivity could cause both hypertension and the metabolic syndrome have been documented. Furthermore, the excessive sympathetic tone is conducive to coronary heart disease through its association with high hematocrit values and with excessive platelet aggregability. Surprisingly, the myth that patients with neurogenic hypertension have a benign prognosis continues to persist. Much of the misunderstanding stems from the idea that patients with neurogenic hypertension, commonly called "white coat" or borderline hypertension, do not develop established hypertension. There is no support for such an assessment; in fact, patients with neurogenic hypertension are at a high risk of future accelerated hypertension. Another misunderstanding relates to differences in hemodynamics between neurogenic and established hypertension. It is true that patients with neurogenic hypertension initially show an increase of cardiac output. However, this later evolves into a classic picture of established high resistance hypertension. The hemodynamic transition is secondary to a decrease in cardiac responsiveness and an increase in vascular responsiveness over the course of hypertension. With passage of time, vascular reactivity increases, yet sympathetic tone tends to decrease. This can be explained by the "blood pressure seeking behavior of the central nervous system." In hypertension, the central nervous system appears to seek a higher blood pressure level and, as the vasculature becomes hyperresponsive, less sympathetic tone is needed to maintain the elevated blood pressure. This decrease of sympathetic tone in later phases of hypertension should not be viewed as a normalization, since sympathetic tone in relationship to vascular hyperresponsiveness remains excessive and the central nervous system maintains a crucial role in sustaining high blood pressure in hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In essential hypertension (EHT), the elevated arterial pressure has been associated with increased central sympathetic output to the heart, kidney and skeletal muscles (11–13).”
From Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive (2001) · cites this paper as [11]
In the citing paper
“These findings have provided support to the theory that the onset of hypertension is associated with sympathetic hyperactivity, while, eventually, the severity of hypertension is maintained, in part, by the occurrence of end-organ structural changes (11,34).”
From Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive (2001) · cites this paper as [11]
In the citing paper
“sympathetic activation in EHT is believed to contribute to cardiovascular risk.13,14”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [13]
Citations
Cites
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,555
Physiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768
Plasma catecholamines and essential hypertension. An analytical review.
Goldstein, D. S. (1983) · Hypertension · doi:10.1161/01.hyp.5.1.86 · Cited by 598
Epinephrine-induced insulin resistance in man
Deibert, D. C., & Defronzo, R. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109718 · Cited by 557
Mild High-Renin Essential Hypertension
Esler, M., Julius, S., Zweifler, A. J., Randall, O. S., Harburg, E., Gardiner, H., & DeQuattro, V. L. (1977) · New England Journal of Medicine · doi:10.1056/nejm197702242960801 · Cited by 529
Self-citationThe Elastic Symmetry of Arterial Segments in Dogs
Patel, D. J., Fry, D. L., & Janicki, J. S. (1969) · Circulation Research · doi:10.1161/01.res.24.1.1 · Cited by 412
Pollare, T., Lithell, H., Selinus, I., & Berne, C. (1988) · Diabetologia · doi:10.1007/bf00271585 · Cited by 354
Role of Parasympathetic Inhibition in the Hyperkinetic Type of Borderline Hypertension
Julius, S., PASCUAL, A. V., & London, R. L. (1971) · Circulation · doi:10.1161/01.cir.44.3.413 · Cited by 336
Self-citationPaffenbarger, R. S., Thorne, M. C., & Wing, A. L. (1968) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120864 · Cited by 327
Reflex sympathetic activation induces acute insulin resistance in the human forearm.
Jamerson, K. A., Julius, S., Gudbrandsson, T., Andersson, O., & Brant, D. O. (1993) · Hypertension · doi:10.1161/01.hyp.21.5.618 · Cited by 311
Self-citation
Cited by
Sorted by citations
Pathophysiology and Therapeutic Potential of Purinergic Signaling
Burnstock, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.5 · Cited by 618
Hypertension, Blood Pressure, and Heart Rate Variability
Schroeder, E. B., Liao, D., Chambless, L. E., Prineas, R. J., Evans, G. W., & HEISS, G. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000100444.71069.73 · Cited by 460
Heart rate variability in type 2 diabetes mellitus: A systematic review and meta–analysis
Benichou, T., Pereira, B., Mermillod, M., Tauveron, I., Pfabigan, D., Maqdasy, S., & Dutheil, F. (2018) · PLOS ONE · doi:10.1371/journal.pone.0195166 · Cited by 419
Purinergic Signaling and Vascular Cell Proliferation and Death
Burnstock, G. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0302.105360 · Cited by 414
Neural influences on cardiovascular variability: possibilities and pitfalls.
Malpas, S. C. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2002.282.1.h6 · Cited by 408
Metadata
- Authors
- JULIUS, S., & NESBITT, S.
- Affiliations
- University of Michigan (US)
- Corresponding author
- JULIUS, S
- Venue
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-11
- Volume
- 9
- Issue
- 11
- Pages
- 113S-120S
- ISSN
- 0895-7061 (ISSN-L)
- OpenAlex
- W1993942986
- Semantic Scholar
- 03fca351e71d6b2381f8e1a352ac81fe79d5a4c3
- Cited by
- 237
- References
- 59
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 6 · 2023: 2 · 2022: 7 · 2021: 9 · 2020: 10 · 2019: 9 · 2018: 7 · 2017: 4 · 2016: 5 · 2015: 7 · 2014: 10 · 2013: 11 · 2012: 10
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r37hl037464-10)
- National Heart, Lung, and Blood Institute (HL-37464)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK20572)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Keywords
- sympathetic hyperactivity, hypertension, autonomic dysfunction, neurogenic hypertension, white coat hypertension, metabolic syndrome, insulin resistance, dyslipidemia, coronary artery disease, platelet aggregation, hematocrit, central blood pressure regulation
- MeSH terms
- Animals, Humans, Hypertension, Sympathetic Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review